Paediatric medicines: Post-authorisation

This section provides information on the European Medicines Agency's activities relating to paediatric medicines during the post-authorisation stage.

For more information on post-authorisation activities, see Post-authorisation.

In this section

• Annual reports on deferrals
• Deadlines for placing paediatric medicines on the market
• Paediatric requirements for variations and extensions to marketing authorisations
• Submitting results of paediatric studies (Article 46)